Based on this, it was suggested that the main contribution to the higher signal in MYCN-amplified neuroblastoma cells compared to MYCN-non-amplified neuroblastoma cells is not due to an increased copy number of the super-enhancer sequence [165]. The gene discussed is MYCN; the disease is neuroblastoma.